Typically, inflammatory mediators, such as cytokines, oxidative stress, and oxidized low-density lipoprotein, elevate TF levels, but recent studies have revealed the relationship between CKD-specific pathogenesis, including uremic toxins, and regulation of TF activity [17,18,19,20]. This evidence concerns the gene TF and chronic kidney disease.